Cite
Modified EASIX scores predict severe CRS/ICANS in patients with acute myeloid leukemia following CLL1 CAR-T cell therapy.
MLA
Zhao, Yifan, et al. “Modified EASIX Scores Predict Severe CRS/ICANS in Patients with Acute Myeloid Leukemia Following CLL1 CAR-T Cell Therapy.” Annals of Hematology, vol. 103, no. 3, Mar. 2024, pp. 969–80. EBSCOhost, https://doi.org/10.1007/s00277-024-05617-y.
APA
Zhao, Y., Zhang, X., Zhang, M., Guo, R., Zhang, Y., Pu, Y., Zhu, H., Liu, P., Zhang, Y., He, X., Lyu, C., Lyu, H., Xiao, X., & Zhao, M. (2024). Modified EASIX scores predict severe CRS/ICANS in patients with acute myeloid leukemia following CLL1 CAR-T cell therapy. Annals of Hematology, 103(3), 969–980. https://doi.org/10.1007/s00277-024-05617-y
Chicago
Zhao, Yifan, Xiaomei Zhang, Meng Zhang, Ruiting Guo, Yi Zhang, Yedi Pu, Haibo Zhu, et al. 2024. “Modified EASIX Scores Predict Severe CRS/ICANS in Patients with Acute Myeloid Leukemia Following CLL1 CAR-T Cell Therapy.” Annals of Hematology 103 (3): 969–80. doi:10.1007/s00277-024-05617-y.